FountainTx is a pioneering brand in the field of aging biology and computation, dedicated to developing innovative therapeutics for chronic degenerative diseases. Their mission is to treat the underlying cause of these diseases by utilizing their proprietary technology to elucidate the biology of cellular resilience. By targeting cellular resilience, FountainTx is leading the way in a new approach to treating the various diseases that arise from aging.

The brand boasts a team of experts in aging research and computation who collaborate to achieve their mission. Their team combines their expertise in aging biology and computation to develop novel therapeutics for chronic degenerative diseases. Key personnel at FountainTx include Dr.

Thomas Rando, a renowned expert in aging research and stem cell biology, who serves as the co-founder and executive chairman of the board of directors. Dr. Joseph Rodgers, co-founder and director of biology, brings 18 years of experience in aging biology and regenerative biology.

Dr. Tom Cheung, another co-founder, is a leading authority in stem cell biology, cell metabolism, and aging research. Dr.

Simon Tsang, the chief business officer, provides invaluable leadership and strategic expertise. Together, FountainTx's team is focused on revolutionizing the treatment of degenerative diseases and improving the quality of life for patients. Through their dedication and innovative approach, they are paving the way for a future where chronic degenerative diseases can be effectively treated at their root causes